ABSCI CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.08 USD | +2.01% |
|
+10.92% | +20.95% |
| Mar. 21 | Earnings Flash (ABSI) ABSCI CORPORATION Reports Q4 Revenue $338,000 | MT |
| Mar. 21 | Absci Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Presenter SpeechAlexander Khan (Executives)Good morning, everyone. On behalf of our team at Ab...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Absci Corporation is a generative artificial intelligence (AI) drug creation company. The Company combines AI with scalable wet lab technologies to create biologics for patients. It has built an Integrated Drug Creation platform to identify novel drug targets, discover biotherapeutic candidates, and generate the cell lines to manufacture them in a single process. The Company uses its platform to predict, identify, design, construct, screen, select and scale production of biologic drug candidates for its partners, and learn from the data it generates. Its SoluPro technology is a multiplex synthetic biology approach that overcomes the limitations of highest-throughput automation labs. The Company supports its generative AI designs with its wet lab's high-throughput functional validation capabilities. It reconstructs prevalent immune-response molecules, such as antibodies from disease tissue and identify their corresponding antigens, offering new therapeutic targets.
Calendar
2024-05-13
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
5.08
USD
Average target price
8.628
USD
Spread / Average Target
+69.84%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +20.95% | 574M | |
| +25.69% | 47.9B | |
| +46.90% | 41.42B | |
| -3.46% | 40.7B | |
| -6.20% | 28.92B | |
| +9.17% | 25.55B | |
| -20.42% | 19.27B | |
| +0.17% | 12.15B | |
| +28.07% | 12.14B | |
| -1.24% | 11.99B |
- Stock Market
- Equities
- ABSI Stock
- News Absci Corporation
- Transcript : Absci Corporation - Special Call
